We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
-10.96%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$263M
AUM Growth
-$39.5M
Cap. Flow
-$2.8M
Cap. Flow %
-1.07%
Top 10 Hldgs %
45.72%
Holding
73
New
1
Increased
23
Reduced
30
Closed
8

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$954K
2
EEFT icon
Euronet Worldwide
EEFT
+$524K
3
PAYC icon
Paycom
PAYC
+$448K
4
STZ icon
Constellation Brands
STZ
+$445K
5
CRM icon
Salesforce
CRM
+$416K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$607K
2
CLB icon
Core Laboratories
CLB
+$516K
3
SLB icon
SLB Ltd
SLB
+$503K
4
PG icon
Procter & Gamble
PG
+$490K
5
ESRX
Express Scripts Holding Company
ESRX
+$455K

Sector Composition

Rank Sector Weight
1 Healthcare 24.89%
2 Technology 20.91%
3 Consumer Staples 10.16%
4 Communication Services 9.93%
5 Financials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
K
51
DELISTED
Kellanova
K
$480K 0.18%
8,967
-1,491
-14% -$90K
CRM icon
52
Salesforce
CRM
$151B
$414K 0.16%
+3,025
New +$416K
CSCO icon
53
Cisco
CSCO
$457B
$383K 0.15%
8,908
– –
KO icon
54
Coca-Cola
KO
$377B
$370K 0.14%
7,877
– –
ENB icon
55
Enbridge
ENB
$119B
$368K 0.14%
11,875
-1,175
-9% -$37.8K
XOM icon
56
ExxonMobil
XOM
$644B
$313K 0.12%
4,596
-1,333
-22% -$105K
ETN icon
57
Eaton
ETN
$161B
$301K 0.11%
4,366
– –
AMZN icon
58
Amazon
AMZN
$2.92T
$282K 0.11%
3,760
+660
+21% +$54.9K
EMR icon
59
Emerson Electric
EMR
$83.9B
$243K 0.09%
4,057
– –
MRK icon
60
Merck
MRK
$322B
$238K 0.09%
3,280
– –
UNH icon
61
UnitedHealth
UNH
$376B
$224K 0.09%
900
– –
BMY icon
62
Bristol-Myers Squibb
BMY
$133B
$213K 0.08%
4,090
-1,150
-22% -$61.8K
BRK.B icon
63
Berkshire Hathaway Class B
BRK.B
$1.1T
$203K 0.08%
997
– –
IMNN icon
64
Imunon
IMNN
$6.68M
$22K 0.01%
112
+51
+84% +$21.2K
GCVRZ
65
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5K ﹤0.01%
10,260
– –
CLB icon
66
Core Laboratories
CLB
$488M
– –
-4,450
Closed -$516K
COP icon
67
ConocoPhillips
COP
$147B
– –
-3,070
Closed -$236K
DD icon
68
DuPont de Nemours
DD
$18.5B
– –
-1,287
Closed -$209K
IBM icon
69
IBM
IBM
$211B
– –
-1,647
Closed -$238K
PM icon
70
Philip Morris
PM
$297B
– –
-2,830
Closed -$232K
SLB icon
71
SLB Ltd
SLB
$73.6B
– –
-8,240
Closed -$503K
TGT icon
72
Target
TGT
$65.6B
– –
-2,925
Closed -$257K
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
– –
-4,790
Closed -$455K
1 2
3

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Dillon & Associates held 73 positions worth $263M, down 13% from $302M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Dillon & Associates's Q4 2018 filing shows 1 new, 23 increased, 30 reduced and 8 closed positions. Its largest new stake was Salesforce: 3,025 shares worth $414K. The largest sale was Celgene Corp, an estimated $607K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Staples.

  • Dillon & Associates's largest Q4 2018 buy was Salesforce: 3,025 shares worth $414K.
  • Dillon & Associates added most to NVIDIA in Q4 2018, an estimated $954K increase.
  • Dillon & Associates's biggest Q4 2018 reduction was Celgene Corp, cutting an estimated $607K.
  • Dillon & Associates fully exited Core Laboratories in Q4 2018, selling an estimated $516K.
  • Dillon & Associates's ten largest holdings make up 46% of its $263M portfolio in Q4 2018.
  • Dillon & Associates opened 1 new position and closed 8 in Q4 2018.
  • Dillon & Associates's portfolio value fell 13% quarter-over-quarter to $263M.

Based on Dillon & Associates's 13F filing for Q4 2018, filed 14 Feb 2019.